Talk to the Institute
Published mark

Jazz Pharmaceuticals plc

NASDAQ: JAZZ. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:949442cd-411d-47fd-9b77-1797c485ab61
SEC CIK
0001232524
Website
www.jazzpharma.com Open
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
May 1, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Bruce C. CozaddSince Jun 6, 2025
Chair
Not published
Independent
11 / 1212 directors published
Published claims
293 distinct sources
Evidence records
140 pinned
Source conflicts
0None open

Built from 3 distinct sources and 14 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

Bruce C. Cozadd executive of Jazz Pharmaceuticals plc, effective 2025-06-06.

EffectiveEffective Jun 6, 2025E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Executive OfficerBruce C. CozaddJun 2025currentSource reportedE3
Senior Vice President & Chief Transformation OfficerGeorge Christopher EliadesNot capturedunknownSource reportedE4
Executive Vice President & Chief People OfficerHeidi MannaNot capturedunknownSource reportedE5
Senior Vice President of Sleep & CNS MedicineJed BlackNot capturedunknownSource reportedE6
Senior Vice President of Corporate StrategyJohn MillerNot capturedunknownSource reportedE7
Senior Vice President of Technical OperationsMary Elizabeth HendersonNot capturedunknownSource reportedE8
Executive Vice President & Chief Legal OfficerNeena PatilNot capturedunknownSource reportedE9
Senior Vice President & Chief Accounting OfficerPatricia CarrNot capturedunknownSource reportedE10
Executive Vice President & Chief Financial OfficerPhilip L. JohnsonNot capturedunknownSource reportedE11
President, Chief Executive Officer & DirectorRenee D. GalaNot capturedunknownSource reportedE12
Executive Vice President, Chief Medical Officer and Global Head of Research & DevelopmentRobert IannoneNot capturedunknownSource reportedE13
Executive Vice President & Chief Commercial OfficerSamantha PearceNot capturedunknownSource reportedE14

Board of directors

Evidence

12 directors published. 11 of 12 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Anne O'RiordanIndependent2019None publishedSource reportedE2
Bruce C. CozaddNot independent2003None publishedSource reportedE2
Heather Ann McSharryIndependent2013None publishedSource reportedE2
Jennifer E. CookIndependent2020None publishedSource reportedE2
Kenneth W. O'KeefeIndependent2004None publishedSource reportedE2
Laura J. HamillIndependent2024None publishedSource reportedE2
Mark D. SmithIndependent2020None publishedSource reportedE2
Norbert G. RiedelIndependent2013None publishedSource reportedE2
Patrick G. EnrightIndependent2009None publishedSource reportedE2
Patrick KennedyIndependent2024None publishedSource reportedE2
Rick E WinninghamIndependent2010None publishedSource reportedE2
Seamus MulliganIndependent2012None publishedSource reportedE2

Committees and risk ownership

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerBruce C. Cozadd, Chief Executive Officer, from Jun 6, 2025
Source reportedE3
company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:19
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingJAZZ (NASDAQ)
Source reportedE1
company:949442cd-411d-47fd-9b77-1797c485ab61:security_listing:31
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameJazz Pharmaceuticals plc
Source reportedE1
company:949442cd-411d-47fd-9b77-1797c485ab61:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:949442cd-411d-47fd-9b77-1797c485ab61:entity_status:3
Published FactHealthcare
Source reportedE1
company:949442cd-411d-47fd-9b77-1797c485ab61:published_fact:6

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • CommitteesNot reviewed. Committee mandates show where oversight is delegated.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
14 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 5 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Jazz Pharmaceuticals DEF 14A 2025-06-06
    sec proxy. Published Jun 6, 2025. Retrieved May 1, 2026. Cited by 12 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    JAZZ DEF 14A executive officers
    sec filing. Published Jun 6, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    Jazz Pharmaceuticals key executives
    other. Published May 1, 2026. Retrieved May 1, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • Bruce C. Cozadd executive of Jazz Pharmaceuticals plc, effective 2025-06-06.
  • Laura J. Hamill seat on Jazz Pharmaceuticals plc, effective 2024-01-01.
  • Patrick Kennedy seat on Jazz Pharmaceuticals plc, effective 2024-01-01.
  • Jennifer E. Cook seat on Jazz Pharmaceuticals plc, effective 2020-01-01.
  • Mark D. Smith seat on Jazz Pharmaceuticals plc, effective 2020-01-01.
  • Anne O'Riordan seat on Jazz Pharmaceuticals plc, effective 2019-01-01.
  • Heather Ann McSharry seat on Jazz Pharmaceuticals plc, effective 2013-01-01.
  • Norbert G. Riedel seat on Jazz Pharmaceuticals plc, effective 2013-01-01.
  • Seamus Mulligan seat on Jazz Pharmaceuticals plc, effective 2012-01-01.
  • Rick E Winningham seat on Jazz Pharmaceuticals plc, effective 2010-01-01.
  • Patrick G. Enright seat on Jazz Pharmaceuticals plc, effective 2009-01-01.
  • Kenneth W. O'Keefe seat on Jazz Pharmaceuticals plc, effective 2004-01-01.
  • Bruce C. Cozadd seat on Jazz Pharmaceuticals plc, effective 2003-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:949442cd-411d-47fd-9b77-1797c485ab61, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/jazz-pharmaceuticals-plc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership12
  4. Board12
  5. Committees0
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims4
  15. Coverage gaps18
  16. Linked people23
  17. Subject and corrections6
  18. Evidence14
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:949442cd-411d-47fd-9b77-1797c485ab61
  • Cite this recordJazz Pharmaceuticals plc
  • Copy canonical URLregistry.alpha.ac/companies/jazz-pharmaceuticals-plc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Jazz Pharmaceuticals plcCompany
  • Bruce C. CozaddPerson
  • George Christopher EliadesPerson
  • Heidi MannaPerson
  • Jed BlackPerson
  • John MillerPerson
  • Mary Elizabeth HendersonPerson
  • Neena PatilPerson
  • Patricia CarrPerson
  • Philip L. JohnsonPerson
  • Renee D. GalaPerson
  • Robert IannonePerson
  • Samantha PearcePerson
  • Anne O'RiordanPerson
  • Heather Ann McSharryPerson
  • Jennifer E. CookPerson
  • Kenneth W. O'KeefePerson
  • Laura J. HamillPerson
  • Mark D. SmithPerson
  • Norbert G. RiedelPerson
  • Patrick G. EnrightPerson
  • Patrick KennedyPerson
  • Rick E WinninghamPerson
  • Seamus MulliganPerson
  • Sections
    OverviewJazz Pharmaceuticals plc
  • MonitoringJazz Pharmaceuticals plc
  • LeadershipJazz Pharmaceuticals plc
  • BoardJazz Pharmaceuticals plc
  • CommitteesJazz Pharmaceuticals plc
  • Control and votingJazz Pharmaceuticals plc
  • Authority to actJazz Pharmaceuticals plc
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.